O[rganelles]{.smallcaps}within the endocytic pathway are dynamic structures, resulting from the fusion and fission of newly internalized vesicles with preexisting structures. The early portion of the endocytic pathway exists in a "steady state." In the absence of continued membrane internalization the early endocytic apparatus virtually disappears and the constituent membrane and contents are then directed to the cell surface and the lysosome ([@B71]; [@B75]). Whereas the lysosome retains its identity in the absence of continued membrane internalization, it is a dynamic organelle capable of undergoing changes both in morphology and size ([@B38]; [@B68]). Studies have indicated that lysosomes can undergo self, or homotypic fusion. Acidification of macrophage cytosol results in the fragmentation of lysosomes into vesicles that are removed from their normal perinuclear location to a more peripheral location ([@B30]; [@B55]). Upon normalization of cytosolic pH, these fragmented lysosomes return to their normal perinuclear location and re-fuse to generate a population of similar size to that found in untreated cells. Perhaps the most dramatic example of homotypic lysosome fusion results from studies in which cells are fused to form a heterokaryon. Lysosomes from each partner (which can be identified through either content markers or species-specific lysosomal membrane proteins \[e.g., Lamp-1,2\]) within the heterokaryons show complete intermixing of contents and membrane ([@B18]; [@B19]; [@B25]; [@B56]).

Although there is abundant evidence that lysosomes can fuse, the mechanisms that regulate fusion, however, are unknown. A diverse series of GTP-binding proteins, ADP ribosylation factors (ARFs) ([@B6]; [@B40]), rabs (Novick and Grennwald, 1993; [@B78]; [@B24]), and trimeric G proteins ([@B10]; [@B13]; [@B41]; [@B60]; [@B77]; [@B8]; [@B52]), have been implicated in regulating fusion events in both the secretory and endocytic pathways (for review see [@B64]; [@B51]; [@B5]; [@B65]). No such proteins have been identified to be either associated with lysosomes or involved in defining lysosome size and shape ([@B3]). The only known protein that affects lysosome size is the Chediak/beige protein ([@B57]), which when absent or defective results in abnormally large lysosomes. Recently, the Chediak/beige protein has been identified ([@B7]; [@B49]; [@B57]), although the deduced sequence of the protein yields no clues as to its function.

In an effort to discern the factors responsible for lysosomal fusion we have devised an in vitro homotypic lysosome fusion assay. In this communication we report on the biochemical characteristics of the assay system, its specificity and the minimal requirements for lysosome fusion in vitro. We demonstrate that lysosomes derived from macrophages have a high capacity for homotypic fusion. Whereas fusion appears to require a heterotrimeric G protein and rab(s), it is independent of microtubules.

Materials and Methods
=====================

Cells
-----

Rabbit alveolar macrophages were obtained by bronchial lavage ([@B48]) and maintained as previously described ([@B34]). J774E cells were grown in αMEM (GIBCO BRL, Gaithersburg, MD) containing 10 μg/ml 2-amino-6-mercaptopurine (Sigma Chemical Co., St. Louis, MO) supplemented with 10% FBS (HyClone Laboratories Inc., Logan, UT).

Materials
---------

Unless otherwise noted, all reagents were obtained from Sigma Chemical Co. Human holo-transferrin was iodinated as described previously ([@B72]). αMacroglobulin was isolated and trypsinized as previously described ([@B35]). Biotinylated horseradish peroxidase (b-HRP)^1^, avidin D, and anti-avidin were obtained from Vector Labs, Inc. (Burlingame, CA). Mastoparan and mastoparan derivatives were obtained from Peninsula Labs (Belmont, CA). Recombinant NSF and dominant-negative NSF (D1E-Q, Glu^3^29 to Gln) were obtained from Dr. S.W. Whiteheart (University of Kentucky, Lexington, KY). Canine guanine nucleotide--dissociation inhibitor (GDI) and bovine GDI were generous gifts from Dr. A. Wandinger-Ness (Northwestern University, Evanston, IL). ELISA plates were obtained from Corning Glass Works (Corning, NY) and prepared with a 1:200 dilution of anti-avidin as described by [@B11]. Cytosol was obtained from either J774E, alveolar macrophages, or rat liver. Filtered cytosol was prepared using spin columns (Bio-Rad Laboratories, Hercules, CA).

Subcellular Fractionation
-------------------------

Cells were incubated in 1 mg/ml b-HRP in HMEM/BSA at 37°C for 45 min, washed extensively, and then chased for an additional 90--120 min. Cells were then incubated in 10^−8^ M ^125^I-transferrin (^125^I-Tf\[Fe\]~2~) in HMEM/BSA for 45 min at 37°C. Cells were washed extensively, and then homogenized in homogenization buffer (HB) (250 mM sucrose, 20 mM Hepes, 0.5 mM EGTA, pH 7.2, KOH) at 35--50 × 10^6^ cells/ml using a ball-bearing homogenizer to ∼50--75% break up. Homogenates were centrifuged at 800 *g* for 5 min at 4°C to obtain a postnuclear supernatant (PNS). PNSs were centrifuged for 3 min at 16,000 *g* to yield crude cytosols and vesicle pellets. Vesicle pellets were resuspended in a small volume of HB and fractionated over 23% Percoll (J774 E cells) or 27% Percoll (alveolar macrophages) as described previously ([@B73],*b*). Gradients were fractionated and HRP activity was assayed on an ELISA plate using 0.8 mg/ml *O*-phenylenediamine and 0.02% H~2~O~2~ in citrate-phosphate buffer, pH 5.0. The reaction was stopped by addition of 6N HCl and read at 490 nm on a kinetic microplate reader (Molecular Devices, Sunnyvale, CA). β-Galactosidase activity was assayed using methylumbelliferyl-β galactoside (Sigma Chemical Co.) as a substrate. ^125^I-Tf activity was measured on an auto-gamma 5780 counter (Packard Instrument Co., Meriden, CT).

In Vitro Fusion Reaction
------------------------

Cells were incubated with either 0.5 mg/ml b-HRP or avidin at 37°C for 45--60 min in Hanks\' minimal essential medium (HMEM). Cells were washed extensively and chased for an additional 90--120 min. Cells were washed and homogenized in HB, and then a PNS was obtained as described above. (Typically the vesicle protein concentration was 1--2 mg/ml with a cytosol protein concentration ranging from 2--4 mg/ml). PNSs and/ or lysosomes (isolated as described) were combined at 4°C in the presence of excess (20--100 μg/ml) b-insulin. Fusion reactions were performed in 250 mM sucrose, 2 mM DTT, 1 mM MgCl~2~, 0.5 mM EGTA, 50 mM KCl, and 20 mM Hepes, pH 7.2 (fusion buffer), plus or minus an ATP regenerating system as described previously ([@B12]) using *O*-phenylenediamine. Reactions were stopped by placing samples at 0°C and solubilizing in 0.05% Triton X-100, 50 mM NaCl, 10 mM Tris-HCl, pH 7.5, 1 mg/ml heparin, 20--100 μg/ml biotinylated insulin. Samples were centrifuged at 16,000 *g*, for 3 min, and the supernatants assayed for avidin-- b-HRP complex formation using precoated anti-avidin ELISA plates as described ([@B11]). In vitro fusion was expressed as a percentage of the maximum avidin--b-HRP complex formation in samples solubilized in the absence of biotinylated insulin. All experiments were performed a minimum of three times.

Lysosome Isolation
------------------

Lysosomes were isolated by fractionating over Percoll gradients ([@B73]), pooling of fractions corresponding to HRP and lysosomal enzyme activity (typically 3--7 of a 20-fraction gradient). The Percoll was then removed by high speed centrifugation (220,000 *g* for 2 h).

Microscopy Studies
------------------

J774E cells or rabbit alveolar macrophages were incubated in HMEM containing either 1 mg/ml fluorescein-dextran (10,000 mol wt) or 0.5 mg/ml Texas red--dextran (10,000 mol wt) (Molecular Probes, Inc., Eugene, OR) at 37°C for 30 min. Cells were washed and incubated in HMEM at 37°C for an additional 90 min. The two cell populations were then washed, mixed, and fused using UV sendai fusion as per [@B56]. After specified times cells were visualized using an inverted fluorescent microscope (Nikon Inc., Torrance, CA) with a ×100 oil immersion objective (Nikon Inc.). Images were acquired using Oncor image analysis software as previously described ([@B75]).

Preparation of Microtubules
---------------------------

Phosphocellulose-purified bovine brain tubulin was a gift from Dr. D. Gard (Department of Biology, University of Utah, Salt Lake City, UT). Microtubules were prepared by serially adjusting 0.66 mg/ml tubulin in 80 mM Pipes, pH 6.8, 1 mM EGTA, 1 mM MgCl~2~, and 1 mM GTP to 0.2 μM, 2.0 μM, and 10 μM taxol with incubations at 4°C for 5 min at each step. This solution was added to reaction mixtures containing 10 μM taxol to achieve a final concentration of 0.033 mg/ml tubulin. The presence of polymerized microtubules was confirmed by immunofluorescence using a monoclonal anti--β-tubulin (ICN Biomedicals, Inc., Costa Mesa, CA) and a Texas red-- conjugated goat anti--mouse secondary (Molecular Probes Inc.). For in vitro studies on microtubules, cytosol was treated with microtubule depolymerizing agents before the in vitro fusion reaction. Protein determinations were performed as described ([@B44]).

Results
=======

Demonstration of In Vitro Homotypic Lysosome Fusion
---------------------------------------------------

The fusion assay relies on the formation of a b-HRP--avidin complex within lysosomes, with the subsequent capture of the complex by anti-avidin antibodies as originally described by [@B11]. One population of cells was incubated with b-HRP, whereas the other cells were incubated with avidin. Cells were exposed to the ligands and subsequently chased in ligand-free media such that the ligands were localized in the lysosome. PNSs or purified lysosomes were mixed together in the presence of b-insulin to capture any released avidin, and samples were incubated at different temperatures and conditions. At the end of the incubation samples were treated with detergent, avidin-- b-HRP complex captured by immobilized antibody, and the amount of complex was determined by measuring HRP activity. Both b-HRP and avidin are mannose-terminal glycoproteins, and are internalized via the mannose-terminal glycoprotein receptor. Experiments were performed using rabbit alveolar macrophages or a clone of the murine macrophage cell line, J774E, as these cell types express high levels of mannose-terminal glycoprotein receptors.

Using the protocol described in Materials and Methods we determined that the pulse--chase procedure resulted in the localization of \>95.0% of the cell-associated ligand within lysosomes as assessed by Percoll gradients. When PNSs were mixed and incubated in vitro, there was a time- and temperature-dependent formation of avidin--b-HRP complexes. Approximately 10--20% of the initial b-HRP activity was found associated with avidin in PNSs incubated at 37°C for 60 min; whereas at 0°C, minimal avidin-- b-HRP complex formation was observed (Fig. [1](#F1){ref-type="fig"}). Similar results were obtained using rabbit alveolar macrophages (data not shown). Since the presence of b-insulin blocked the formation of adventitious avidin--b-HRP complexes released as a result of vesicle breakage, formation of avidin--b-HRP complexes could only result from vesicle fusion. The contents of an alveolar macrophage fusion assay were fractionated on Percoll gradients before addition of detergent. Avidin--b-HRP complexes cosedimented with the lysosomal marker hexoseaminidase indicating that the complex was a result of fusion and not binding of free ligands (Fig. [2](#F2){ref-type="fig"}). The data indicate that the products of the in vitro fusion may result in a slight change in the buoyant density of lysosomes, the avidin--b-HRP peak and hexoseaminidase peaks do not completely coincide. One explanation of this result is that the fusion products may be larger and consequently be less dense.

Specificity of Lysosome Fusion
------------------------------

PNSs contain many vesicle populations. It is possible that the ligand may not be solely restricted to lysosomes, and that complex formation results from other vesicles, e.g., endosomes fusing with each other or with lysosomes. To address this point, lysosomes purified from Percoll gradients were used in the fusion assay. PNSs from either avidin- or b-HRP--loaded J774E cells were layered over 23% Percoll and centrifuged to separate lysosomes from endosome/Golgi vesicles. Previously, we demonstrated that Golgi as well as late endosomes are fairly coincident with early endosomes, but are well separated from lysosomes on Percoll gradients ([@B2]; [@B73],*b*). As demonstrated in Fig. [3](#F3){ref-type="fig"} *A*, lysosomes in J774E cells show a biphasic buoyant density in which ∼50% of the lysosomes, as defined by β-galactosidase or hexoseaminidase activity (data not shown), were well separated from ^125^I-Tf--containing endosomes. Lysosomes in many cell types show heterogeneous buoyant densities ([@B36]; [@B16]). Alternatively, the less dense peak of hexoseaminidase may also represent a late endosomal population. Studies are currently underway to determine the fusogenic nature of different vesicle populations along the endocytic pathway. To avoid the possibility of endosomal contamination, the dense fractions of lysosomal activity (fractions 3--7), were pooled and used for a fusion assay in the presence or absence of an ATP-regenerating system (Fig. [3](#F3){ref-type="fig"} *B*). The degree of fusion seen using this enriched lysosome preparation was equal to or greater than that seen using the corresponding PNS. In many experiments the degree of fusion was as high as 30% of the input b-HRP.

The specificity of the fusion reaction was further demonstrated using rabbit alveolar macrophages. Percoll gradient fractionation of cellular homogenates showed a single buoyant density peak of lysosomes that was well separated from both early and late endosomes ([@B73],*b*). Previous studies using macrophages determined that brief exposure of cells to endocytic ligands results in the localization of those ligands strictly to the early endocytic apparatus ([@B20]; [@B74]). Homotypic in vitro fusion can readily be demonstrated for purified early endosomes as well as purified lysosomes (Fig. [4](#F4){ref-type="fig"}). However, no evidence of fusion between early endosomes and lysosomes was observed, indicating again the highly selective nature of the fusion process. These results support other studies that have demonstrated the specificity of homotypic vesicle fusion ([@B20]; [@B27]; Colombo et al., 1992).

Homotypic Lysosome Fusion In Vivo
---------------------------------

To demonstrate that the high degree of fusion was not due to an in vitro artifact, we assessed the degree and rate of lysosome fusion using an in vivo experiment. Cells, containing different fluorescently labeled lysosomes, were fused together and lysosome fusion assessed by the coincidence of the two fluorescent dyes. Cells, labeled separately with either fluorescein-dextran or Texas red dextran, were fused using UV sendai virus as described ([@B25]; [@B56]). Heterokaryons began showing a small amount of coincidence of fluorescent dextrans as early 15 min with almost complete coincidence evident at 1--3 h (Fig. [5](#F5){ref-type="fig"}). Nonfused cells on the same cover slip did not contain the second dye, eliminating the possibility that cells released and reaccumulated the fluorescent dye. Multiple fields were scanned and in fused cells the majority (70--90%) of lysosomes contained both dyes. This result indicates that homotypic lysosome fusion is not a rare event but in fact is highly frequent.

Biochemical Requirements of Homotypic Fusion
--------------------------------------------

In vitro fusion was dependent upon cytosol, but the origin of the cytosol was irrelevant. Similar results were obtained using cytosol from cultured cells, isolated rabbit macrophages, or mouse liver homogenates (data not shown). Fusion in vitro was ATP dependent, as depletion of endogenous ATP by addition of glucose and hexokinase resulted in the complete inhibition of lysosome fusion (Table [I](#TI){ref-type="table"}). Treatment of cytosol with NEM resulted in the complete loss of fusion activity, suggesting that homotypic lysosome fusion, like almost all other fusion events, was dependent on an NEM-sensitive factor that may be NSF ([@B9]). Addition of recombinant NSF in the absence of cytosol reconstituted fusion activity. Further, addition of purified NSF completely reconstituted fusion activity in the presence of NEM-treated cytosol, and did not enhance fusion activity when added to untreated cytosol. Under similar conditions a mutant NSF, unable to hydrolyze ATP (D1E-Q, Glu^329^ to Gln), did not promote fusion. Further, this mutant NSF acted as a dominant negative and inhibited fusion when added back to a complete reaction with cytosol. These results demonstrate that NSF and its ability to hydrolyze ATP are required for homotypic lysosome fusion. The data also suggest that the only soluble protein required is NSF; all other proteins are lysosome bound.

Previous studies on in vivo, as well as in vitro vesicle fusion have demonstrated the role of GTP-binding proteins (for review see [@B26]; [@B63]). No GTP-binding proteins have been identified that are associated with lysosomes ([@B3]). Studies in yeast have demonstrated the role of yeast Ypt7 in vacuolar inheritance and vacuole fusion in vitro ([@B14]; [@B28], [@B29]). The mammalian analogue of Ypt7 is rab7, which has been shown to be associated with late endosomes ([@B3]; [@B4]; [@B24]). To determine if a GTP-binding protein may be involved in lysosome--lysosome fusion, we added the nonhydrolyzable analogues GTPγs or GDPβs to the in vitro fusion reactions. Fig. [6](#F6){ref-type="fig"} demonstrates that GTPγs and GDPβs inhibited fusion in a concentration- dependent manner.

The concentration of GTP analogues that inhibited fusion ranged from 50--200 μM, a range slightly higher than that required for inhibition of other vesicle fusions ([@B10]; Colombo et al., 1992*b;* [@B8]). This concentration was similar, however, to that required to inhibit homotypic yeast vacuolar fusion ([@B14]; [@B28], [@B29]). The fact that GTPγs inhibits lysosome--lysosome fusion in vitro suggests that a GTP-binding protein(s) is involved. GDI prevents the dissociation of GDP from a variety of rab proteins ([@B66]) and has been shown to inhibit several in vitro vesicle fusion reactions ([@B21]; [@B23]; [@B58]; [@B1]; [@B29]; Ikonen et al., 1995; [@B70]). Addition of GDI inhibits lysosome--lysosome fusion in vitro, whereas heat-inactivation of GDI before addition to the fusion reaction completely blocked the inhibitory effect (Table [II](#TII){ref-type="table"}). These data suggest that a rab protein is required for homotypic lysosome fusion.

Previous studies have also demonstrated the involvement of heterotrimeric G proteins in vesicle fusion ([@B13]; Pimplikar and Simon, 1993; [@B28]). Mastoparan, a heterotrimeric, G protein activator (Fig. [7](#F7){ref-type="fig"}) inhibited in vitro lysosome fusion, whereas addition of the inactive analogue Mas-17 had no inhibitory effect on in vitro lysosome fusion. To define the heterotrimeric G protein involved in homotypic lysosome fusion, Cholera toxin (Chtx), a Gα~s~ activator and Pertussis toxin (Ptx), a Gα~i~ activator were added to the fusion reaction. Cholera toxin has been shown to specifically activate Gα~s~ and studies on endosome--endosome fusion have demonstrated the role of a heterotrimeric Gα~s~ in early endosome fusion ([@B13]). Ptx, on the other hand, has been shown to specifically activate Gα~i~ and studies have shown a Gα~i~ to be involved in regulation of apical transport in epithelial cells (Pimplikar and Simon, 1993). As demonstrated in Table [III](#TIII){ref-type="table"} Ptx inhibited in vitro lysosome fusion while Chtx did not inhibit fusion. The inhibitory activity was dependent on the presence of NAD, which activates the toxin.

Role of Microtubules in Lysosome Fusion
---------------------------------------

Studies on in vitro endosome--endosome fusion and late endosome--lysosome fusion have demonstrated the need for polymerized microtubules ([@B27]; [@B4]; [@B46], [@B47]). It is clear that microtubules can affect lysosome distribution and shape in macrophages ([@B30]; [@B33]; [@B37]; [@B42]; [@B69]; [@B55]; [@B54]). Their role, however, in affecting lysosomal fusion events is less clear. Incubation of alveolar macrophages with either nocodozole or colchicine resulted in the disruption of microtubules (data not shown) but had minimal effects on movement of internalized ligands through the endocytic system to the lysosome (Fig. [8](#F8){ref-type="fig"} *A*). Similarly, microtubule disruption (data not shown), or addition of taxol-stabilized microtubules did not alter the rate or extent of in vitro lysosome fusion (Fig. [8](#F8){ref-type="fig"} *B*). The presented experiment was performed using a microtubule concentration of 0.033 mg/ml, similar to previous studies ([@B27]). A fivefold increase or decrease in microtubule concentration had no effect on the extent or kinetics of homotypic lysosome fusion (data not shown). Based on these results we conclude that neither fusion of endocytic vesicles with lysosomes nor homotypic lysosome fusion in alveolar macrophages is dependent upon microtubules.

Discussion
==========

A variety of studies have defined molecules responsible for both internalization of plasma membrane vesicles, homotypic endosome fusion, and fusion of Golgi vesicles to late endosomes ([@B43]; [@B59]; [@B26]; [@B63]). Similar studies have been carried out in the secretory pathway ([@B65]). These studies have used in vitro assays as well as molecular biology techniques to define the machinery for vesicle recognition, fusion, and fission. Such experiments have been buttressed by genetic studies in yeast. In many respects, the machinery for vesicle transport in yeast is homologous with those in mammalian cells, facilitating the identification of putative genes and gene products ([@B62]; [@B67]). The biochemical requirements for yeast vacuolar fusion in vitro, have recently been defined. Vacuolar fusion is involved in vacuolar inheritance ([@B14], [@B15]; [@B28], [@B29]; [@B45]). Less is known, however, about the mechanisms that regulate lysosome fusion and fission in mammalian cells.

Lysosomes are known to obtain membrane and vacuolar contents from endocytosis and de novo--synthesized enzymes from the Golgi apparatus through the late endosome via vesicle fusion events. Membrane fusion was suggested by [@B17] to explain the relationship between lysosomes, phagosomes, digestive vacuoles, and residual bodies. In general, however, it has not been well appreciated that lysosomes exhibit extensive rounds of self- or homotypic fusion. Studies by [@B53] demonstrated fusion of lysosomes (termed phagolysosomes) in vitro in homogenates obtained from *Acanthamoeba castellanii.* Storrie and colleagues first observed lysosome fusion in mammalian cells using an assay based on somatic cell fusion ([@B25]; [@B18]). Their studies demonstrated that both the contents and membranes of lysosomes underwent mixing. [@B56] took advantage of the cell fusion approach to devise an assay for the Chediak/*beige* gene product. Cultured Chediak cells when fused with wild-type cells undergo lysosomal mixing and the fused lysosomes then showed the phenotype of the normal parent. This observation formed the basis of a complementation assay that resulted in the identification of the Chediak/*beige* gene ([@B49]; [@B57]). These studies also demonstrate that lysosomal mixing occurs and further, that mechanisms exist which regulate the size of lysosomes.

The studies presented here extend these in vivo observations. The in vivo experiments, as demonstrated in Fig. [5](#F5){ref-type="fig"}, showed that lysosomal fusion is both extensive and rapid. Intermixing of the contents of lysosomes began as early as 15 min of heterokaryon formation where maximum fusion was observed in 90--120 min. It is possible that the observed mixing in vivo may be explained either by unidirectional movement between lysosomes, or by bidirectional movement between late endosomes and lysosomes where late endosomes may also be fusing. The in vitro assay, however, recapitulates the rapidity and extent of lysosomal fusion seen in vivo. Using PNSs as a source of lysosomes, we observed a maximum extent of fusion ranging from 7 to 20% of input b-HRP. When purified lysosomes were used the degree of fusion reached as high as 30% of input b-HRP. Since our system does not detect self-fusion of HRP vesicles or self-fusion of avidin vesicles, we feel that we might be underestimating the actual degree of fusion. There are two explanations why the degree of fusion is higher in the purified lysosome preparation. (*a*) Lysosomes may aggregate through the isolation procedure and thus be in closer physical proximity; and (*b*) the purification of lysosomes results in lowered levels of other membranous systems (Golgi, ER, early and late endosomes) that compete for soluble fusion proteins and/or nucleotides. These explanations are not mutually exclusive.

Lysosome fusion relies on cytosolic factors and nucleotides as do most but not all fusion systems. The source of cytosol was irrelevant. Liver, alveolar macrophage, and cultured cell J774E cytosol supported fusion to the same extent. NSF is required for most fusion systems (for review see [@B65]) and may well be rate limiting in an in vitro system due to competition by different vesicle systems. Addition of wild-type NSF to the in vitro lysosome--lysosome fusion reaction, in the absence of cytosol, resulted in reconstitution of fusion activity. Addition of an NSF analogue, which is unable to hydrolyze ATP, did not result in lysosome--lysosome fusion. This NSF analogue also acts as a dominant-negative component that inhibited in vitro fusion in the presence of cytosol. The fact that recombinant NSF could replace cytosol in the fusion suggests that all other required macromolecular factors are membrane bound.

Whereas the source of cytosol was irrelevant, what appeared to be relevant was the source of lysosomes and the physiological state of the cells before fractionation. The cultured line J774E gave variable results, with different degrees of fusion depending on the culture conditions. PNSs obtained from cells cultured in 5% serum were consistently less fusogenic then were lysosomes obtained from cells in 10% serum (data not shown). (This applied to in vitro endosome fusion as well.) Lysosomes from alveolar macrophages gave higher degrees of fusion than lysosomes from cultured mouse bone marrow macrophages (data not shown). The reasons for the differences in fusion are unknown. Cell-type differences in lysosomal fusion can, however, be seen in vivo. In alveolar macrophage heterokaryons, lysosome fusion occurs within 1--3 h, while a similar degree of fusion takes 4--6 h in cultured human or murine fibroblasts ([@B56]). The kinetics of lysosomal fusion using PNS from J774 cells appeared to show a slight lag (compare with Fig. [1](#F1){ref-type="fig"}), whereas in alveolar macrophages no lag was observed using either PNS or purified lysosomes (compare with Fig. [8](#F8){ref-type="fig"}). These data further demonstrate that there is cell-type difference in fusion in vivo as well as in vitro.

Multiple studies have identified critical roles for GTP-binding proteins in vesicle trafficking pathways in the secretory and endocytic pathways ([@B50]; [@B59]; [@B26]; [@B65]). Studies have localized rabs to a number of different endocytic vesicles. For example, rab4 and rab5 are found on early endosomes, rab7 on late endosomes, and rab9 on *trans*-Golgi elements ([@B78]). Recently [@B70] demonstrated that a rab protein is involved in homotypic ER fusion. To date no rabs, ARFs, or trimeric G proteins have been identified being associated with lysosomes. Our data suggests that such molecules must play a role in homotypic lysosome fusion. Addition of the nonhydrolyzable GTPγs analogue, GDI, or mastoparan, an activator of heterotrimeric G proteins ([@B31], [@B32]) inhibits homotypic lysosome fusion. We also observed that treatment of lysosomes with Ptx inhibited fusion. Other studies have demonstrated the involvement of heterotrimeric G proteins in vesicle fusion ([@B13]; [@B39]; [@B60]; [@B28]). Since Ptx requires ARF activity to catalyze incorporation of the target trimeric G protein, this result suggests that an ARF activity must also be membrane bound.

What is the need for extensive homotypic lysosome fusion? One reasonable explanation is that fusion events redistribute luminal contents among the population of lysosomes. Fusion of lysosomes with a late endocytic vesicle results in the contents of that vesicle being subject to the action of lysosomal hydrolases. In many respects, particularly as a result of phagocytosis or macropinocytosis, a single lysosome may fuse with a phagocytic vacuole or a large endocytic vesicle ([@B61]; [@B54]). The lysosome then obtains material as a bolus. Multiple rounds of lysosomal fusion and fission may guarantee that the amount of substrate in a given lysosome does not overwhelm the amount of lysosomal enzymes available for degradation. Thus, lysosomal fusion may ensure that substrates are always exposed to conditions in which there is an excess of degradative enzymes.

The data in Fig. [2](#F2){ref-type="fig"}, on alveolar macrophages, gives an indication that in vitro fusion may result in a slight change in buoyant density of lysosomes. The avidin--b-HRP peak and hexoseaminidase peaks do not completely coincide. One explanation of this result is that the fusion products may be larger and consequently less dense.

Whereas our current in vitro assay does not demonstrate it, membrane economics suggest that there must be a corresponding fission event. This is demonstrated by the heterokaryon studies in which extensive lysosome fusion occurs, yet the resulting size distribution reflects the original population ([@B18]; [@B19]). Fusion between Chediak and normal cells results in the normal cell phenotype predominating ([@B56]). Even when fusion occurs between Chediak cells, the resulting lysosome size is not a multiple of the original lysosome but reflects the size distribution of the parental cells. The inescapable conclusion is that once fused, lysosomal fission must occur. Lysosome fusion and fission may not only redistribute the contents of vesicles within cells but generate new lysosomes. Studies on vacuolar inheritance in yeast have shown that fission is required for specific vesicles to be inherited by daughter cells ([@B76]). Studies are currently underway to determine if lysosome fission is also occurring in vitro and what components are required for lysosome fission.

Lysosomes, as terminal organelles in the endocytic pathway, are continually obtaining solute and membrane from both the endocytic apparatus and the Golgi apparatus. Clearly, increased membrane influx must be balanced by a corresponding loss of membrane ([@B22]). There are several possible fates for maintaining membrane homeostasis: recycling to the cell surface, increased degradation (i.e., as seen in multivesicular bodies), and membrane fission. Our data suggests that membrane fission may be a way of dealing with this excess membrane, particularly in conjunction with fusion events. A dynamic fusion/fission system would allow for the generation of new vesicles of a defined size class, providing a uniform size population. Further studies are underway to identify the biochemical requirements for lysosome fusion as well as fission.
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![Time and temperature dependent in vitro lysosome--lysosome fusion. J774E cells were incubated at 37°C for 45--60 min with either 0.5 mg/ml avidin or 0.5 mg/ml b-HRP. Cells were washed extensively and chased for an additional 90--120 min, and then homogenized. The homogenate was centrifuged at 800 *g*, for 5 min to obtain a PNS. Typically the vesicle concentration was 1--2 mg/ml with a cytosol protein concentration ranging from 2--4 mg/ml. PNSs from cells labeled with either b-HRP or avidin were combined in the presence of excess b-insulin (20--100 μg/ml), 1 mM MgCl~2~, 2 mM DTT, 50--75 mM KCl, ± an ATP-regenerating system at 0°C or 37°C for specified times. At the end of the incubation period, vesicles were solubilized in a Triton X-100--containing buffer with excess b-insulin and assayed as described in Materials and Methods. The percent in vitro fusion was calculated using the maximum avidin--b-HRP complex formation in the absence of b-insulin as the denominator.](JCB.29127f1){#F1}

![Percoll Gradients of in vitro lysosome--lysosome fusion. In vitro fusion was performed as described in Fig. [1](#F1){ref-type="fig"} using alveolar macrophages. At the end of the fusion reaction, the PNSs were loaded onto 27% Percoll gradients and subcellular fractionation performed as described in Materials and Methods. Alveolar macrophages yield a single peak of lysosomal activity (Ward et al., 1990). Fractions were assayed for hexoseaminidase activity as well as avidin--b-HRP complex formation in the presence and absence of excess b-insulin. The data are expressed as a percentage of the total activity.](JCB.29127f2){#F2}
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Lysosome isolation and in vitro fusion. J774E cells were incubated with either b-HRP or avidin as described in Fig. [1](#F1){ref-type="fig"}. Cells were then incubated with ^125^I-Tf(Fe)~2~ at 37°C for 30 min. PNSs were obtained and centrifuged at 10,000 *g*, for 30 min. Pellets were resuspended in homogenization buffer and layered over 23% Percoll density gradients. Samples were centrifuged at 59,000 *g* for 27 min and fractionated into 20 samples. *A* is a representative gradient showing endosomes (*^125^I-TF*) and lysosomes (*HRP* as well as *β-Gal* activity). Fractions 3--7 were pooled and centrifuged at 220,000 *g* for 90 min to remove Percoll. The lysosomal pellet was obtained and washed once in HB before resuspension in either fresh or frozen cytosol. In vitro fusion was performed on PNS as well as lysosome pellets and the percent fusion determined (*B*) as described in Materials and Methods.
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![In vitro endosome--endosome and lysosome--lysosome in alveolar macrophages. Cells were incubated at 37°C with 0.5 mg/ml b-HRP or avidin for either 5 min (endosome) or 45 min, followed by a 90 minute chase period (lysosome). Cells were homogenized, PNS was obtained and layered over separate 27% Percoll gradients, and then subcellular fractionation was performed as described in Fig. [3](#F3){ref-type="fig"}. Endosomes (fractions 11--16) and lysosomes (fractions 3--7) were isolated and Percoll removed before in vitro vesicle fusion as described in Materials and Methods.](JCB.29127f4){#F4}

![Lysosome--lysosome fusion in vivo. To determine if lysosome--lysosome fusion occurred in vivo, alveolar macrophages were loaded with either 1 mg/ml FITC-dextran or 0.5 mg/ml Texas red--dextran at 37°C for 30 min. Cells were washed and incubated for an additional 90 min in HMEM. Cells were then fused using UV sendai virus protocols as described in Materials and Methods. Cells were washed, plated onto glass coverslips, and then placed back in HMEM at 37°C for various times and examined by fluorescence microscopy.](JCB.29127f5){#F5}

###### 

Biochemical Requirements for In Vitro Lysosome--Lysosome Fusion

  Experimental treatment               Percent fusion
  --------------------------------- -- ----------------
  − ATP                                 3.6 ± 0.9
  \+ ATP                               21.4 ± 1.8
  \+ ATP, wt NSF                       21.0 ± 2.0
  \+ ATP, + d.m. neg. NSF               1.5 ± 0.4
  \+ ATP, − cytosol                     1.8 ± 0.2
  \+ ATP, + NEM cytosol                 0.8 ± 0.5
  \+ ATP, − cytosol, + wt. NSF         21.5 ± 2.0
  \+ ATP, + NEM cytosol, + wt NSF      18.0 ± 1.0
  \+ ATP, + Hexokinase                  1.8 ± 0.0

Purified lysosomes from cells incubated with either avidin or b-HRP were isolated as described in Materials and Methods. Lysosomes were pelleted at 16,000 *g* for 3 min to either remove cytosol or treat cytosol with 1 mM NEM as per [@B11]. Lysosomes from avidin and b-HRP cells were resuspended in either HB, filtered cytosol, wild-type NSF, dominant-negative NSF (D1E-Q, a Glu^329^ to Gln), or NEM-treated cytosol in the presence or absence of an ATP-regenerating system and fusion buffer. Hexokinase (25 U/ml) and glucose were added to the fusion reaction as described by [@B12] and in vitro fusion assessed as described in Materials and Methods.  

![Effects of GTPγs and GDPβs on in vitro lysosome--lysosome fusion. Lysosomes from alveolar macrophages loaded with avidin or b-HRP were combined in gel- filtered cytosol and in vitro fusion reactions performed in the presence of an ATP- regenerating system plus or minus various concentrations of GTPγs or GDPβs.](JCB.29127f6){#F6}

###### 

GDI Addition to In Vitro Lysosome--Lysosome Fusion

  Sample                Percent fusion
  ------------------ -- ----------------
  \+ ATP                20.9 ± 0.5
  − ATP                  1.0 ± 0.1
  10 μg/ml bGDI          0.9 ± 0.6
  50 μg/ml bGDI          0.0 ± 0.1
  HI 50 μg/ml bGDI      15.5 ± 0.7
  10 μg/ml cGDI          0.7 ± 0.0
  50 μg/ml cGDI          0.0 ± 0.0
  HI 50 μg/ml cGDI      14.9 ± 0.8

Lysosomes were isolated as in Table [I](#TI){ref-type="table"}. In vitro reactions were performed as described with or without various concentrations of purified canine or bovine GDI. Samples of GDI were also heat inactivated by boiling for 5 min before addition to the fusion reaction. *cGDI*, is GDI purified from canine; *bGDI*, is purified from bovine; and *HI*, heat inactivation.  

![Effects of mastoparan and Mas-17 on in vitro lysosome--lysosome fusion. Lysosomes from alveolar macrophages loaded with avidin or b-HRP were treated plus or minus various concentrations of mastoparan or Mas-17. Lysosomes were resuspended in filtered cytosol, combined in the presence of an ATP-regenerating system and in vitro fusion reactions performed as described in Materials and Methods.](JCB.29127f7){#F7}

###### 

Effect of Gα Activators on In Vitro Lysosome--Lysosome Fusion

  Sample                    Percent fusion
  ---------------------- -- ----------------
  \+ ATP                    33.0 ± 0.5
  − ATP                      2.0 ± 1.0
  10 μg/ml Ptx              10.9 ± 0.7
  50 μg/ml Ptx               0.5 ± 0.0
  50 μg/ml Ptx, − NAD       26.2 ± 0.3
  10 μg/ml Chtx             30.9 ± 0.8
  50 μg/ml Chtx             32.5 ± 0.4
  50 μg/ml Chtx, − NAD      26.9 ± 0.6

In vitro fusion was carried out as described in Materials and Methods using purified lysosomes. Toxins were pretreated with DTT preincubation as described previously ([@B13]). Treated toxin and NAD were added to the vesicles and the complete fusion reaction was added subsequently.  

###### 

(*A*) Movement of ligand from endosomes to lysosomes in nocodozole-treated alveolar macrophages. Cells were incubated at 37°C for 120 min with or without 10 μM nocodozole. Cells were then pulsed with 10^−8^ M α macroglobulin (M)^125^I-trypsin (T) at 37°C for 3 min in the presence or absence of nocodozole. Cells were placed at 0°C, washed, and then placed back at 37°C in the presence or absence of nocodozole for 45 min. Cells were washed, homogenized, and then subcellular fractionation was performed on Percoll gradients. Fractions were assayed for hexoseaminidase and radioactivity. The data are expressed as the percent of αM.^125^I-T within each fraction. The inset represents the percent movement to lysosomes (coincident with hexoseaminidase or the bottom two fractions) where "pulse" is the amount of radioactivity coincident with lysosomes in cells only pulsed with ligand for 3 min (\<5%). "Chase" is the amount of radioactivity coincident with lysosomes in cells incubated for extended times without nocodozole (54%) and nocodozole-treated cells (46%). (*B*) Kinetics of in vitro lysosome-- lysosome fusion in the presence or absence of polymerized microtubules. Isolated lysosomes from alveolar macrophages loaded with avidin or b-HRP were combined for in vitro fusion in the presence or absence of polymerized microtubules as described in Materials and Methods. At various times samples were removed and the amount of fusion determined as described.
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